Navigation Links
Nerve Stimulation Device Doesn't Ease Most Back Pain
Date:12/30/2009

Review finds little evidence of relief with technology called TENS

WEDNESDAY, Dec. 30 (HealthDay News) -- If you're thinking of using the portable device called transcutaneous electric nerve stimulation (TENS) to ease your chronic low back pain, the American Academy of Neurology has some advice for you: Don't bother.

There are no controlled studies showing that TENS is effective against back pain of unknown origin persisting for three months or longer, said Dr. Richard M. Dubinsky, a professor of neurology at Kansas University Medical Center and chair of practice improvement for the academy. He is the lead author of a review article on the technology in the Dec. 30 online issue of Neurology.

"We did a systematic research review, also looking at a database for clinical trials," Dubinsky said. "We found very few of sufficient quality to analyze. We were looking for studies which were controlled by use of a placebo, and also had a sufficient number of subjects."

All but one of the studies excluded people whose back pain had known causes, such as a pinched nerve, severe scoliosis (curvature of the spine), displacement of a backbone or vertebra, or obesity. Those studies showed no benefit of TENS for chronic pain. The one study that looked at low back pain associated with known conditions found no benefit, the study authors noted.

An exception was diabetic nerve pain, also known as diabetic neuropathy, which can cause symmetrical numbness, decreased sensation and a feeling of burning, usually involving the legs but sometimes affecting the hands, Dubinsky said. There is good evidence that TENS is effective in this condition, which develops in about 60 percent of people with diabetes, he said.

TENS uses a portable, pocket-sized device to apply a mild electric current to the nerves through electrodes placed against the skin. It has been used for pain relief in a number of disorders for years, even though there is no established theory about how it may provide relief for pain. One theory is based on the belief that nerves can carry only one signal at a time, and that the stimulation provided by the device prevents the pain message from getting through to the brain.

TENS is widely available and widely advertised, but "just because it is popular doesn't mean that it works," Dubinsky said. Approval of TENS by the U.S. Food and Drug Administration doesn't mean much either, he added.

"The threshold for approval by the FDA is different for devices than for pharmaceuticals," Dubinsky said. "For a device, you just have to prove that it is safe. For a pharmaceutical, you have to prove that it is safe and effective."

It's possible that TENS is effective against some forms of pain, such as what is experienced after surgery, but such studies haven't been done, he said.

The demand for relief of back pain -- acute and chronic -- is large; the U.S. National Institute of Neurological Disorders and Stroke estimates that it is the second-most common neurological ailment in the country. It is estimated that about one-quarter of all Americans experience some sort of back pain in any given three months.

Effective treatments for back pain include exercise, stretching and anti-inflammatory medications, including over-the-counter nonsteroidal drugs (NSAIDs) such as ibuprofen, Dubinsky said.

More information

Causes and treatment of back pain are described by the U.S. National Library of Medicine.



SOURCES: Richard M. Dubinsky, M.D., M.P.H., professor, neurology, Kansas University Medical Center, Kansas City; Dec. 30, 2009, Neurology, online


'/>"/>
Copyright©2009 ScoutNews,LLC.
All rights reserved

Related medicine news :

1. Nerve-cell transplants help brain-damaged rats fully recover lost ability to learn
2. 1 small step for neurons, 1 giant leap for nerve cell repair
3. Drug Combo May Offer Best Relief for Nerve Pain
4. New Survey of People With Diabetic Nerve Pain Shows the Condition Significantly Impacts Daily Activities Such as Exercise and Sleep Yet Often Goes Untreated
5. New Stress-Busting Drink Tranquila(TM) Quenches Jangled Nerves
6. One step closer to an artificial nerve cell
7. High Blood Fats Tied to Diabetic Nerve Loss
8. Preoperative MR may assist surgeons in nerve sparing during robotic prostatectomy
9. Lab-grown nerves promote nerve regeneration after injury
10. Unique nerve-stimulation device proves effective against epilepsy
11. Turning down gene expression promotes nerve cell maintenance
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:2/24/2017)... ... February 24, 2017 , ... WHAT: ... networking and recognition opportunities as well as advocacy for the state and region‘s ... on February 23. The Council's Innovation Forecast event highlights innovation throughout the ...
(Date:2/24/2017)... ... , ... With millions of Americans and people worldwide struggling ... are aware of our options and are empowered with strength and information throughout ... its newest edition of "Vision and Hearing" in USA Today, that will educate ...
(Date:2/24/2017)... , ... February 24, 2017 , ... Yisrayl Hawkins, Pastor ... on Bible Prophecy concerning this present generation. Yisrayl makes an astounding statement when ... generation. He explains that the Bible details the current times so plainly that ...
(Date:2/24/2017)... ... February 24, 2017 , ... Congratulations to ... Elite division on February 12th. Ms. Esparza qualified into this prestigious status ... competition held in Las Vegas, Nevada. Frida is one of approximately 25 gymnasts ...
(Date:2/23/2017)... ... February 23, 2017 , ... ... to funding innovative lymphoma research and serving the lymphoma community through a comprehensive ... the La Gorce Country Club in Miami Beach to host its Swirl: Miami ...
Breaking Medicine News(10 mins):
(Date:2/24/2017)... YORK , Feb. 23, 2017  The ... 330.6 million by 2021 from USD 275.9 million ... Read the full report: http://www.reportlinker.com/p04718602-summary/view-report.html ... increasing spending on pharmaceutical R&D, and growth in ... driving the market growth for particle counters. On ...
(Date:2/23/2017)... , Feb 23, 2017 Research and Markets ... Price Analysis and Strategies - 2016" report to their offering. ... The latest ... provides drug pricing data and benchmarks in the global Autism Spectrum ... What are the key drugs marketed for Autism ...
(Date:2/23/2017)... CITY, Calif., Feb. 23, 2017 Nevro Corp. (NYSE: ... evidence-based solutions for the treatment of chronic pain, today reported ... December 31, 2016. 2016 Accomplishment & Highlights: ... full year 2016, an increase of 228% as reported, over ... for 2016, an increase of 612% over the prior year ...
Breaking Medicine Technology: